Submissions received by the Committee

Submissions may be re-ordered by clicking on a column header. They may also be grouped by Organisation/Individual, State/Territory.

Data pager
Data pager
Page size:
 44 items in 3 pages
Data pager
Data pager
Page size:
 44 items in 3 pages
1Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (PDF 284 KB) 
2Australasian Tuberculosis Forum (PDF 106 KB) 
3AusBiotech (PDF 186 KB) 
4Roche Products Pty Ltd (PDF 418 KB) 
5Melanoma Patients Australia (PDF 41 KB) 
6Pharmaceutical Society of Australia (PDF 202 KB) 
7IVD Australia (PDF 234 KB) 
8Medical Technology Association of Australia (PDF 1156 KB) 
9Novartis (PDF 222 KB) 
10ACON (PDF 486 KB) 
11Complementary Medicines Australia (PDF 337 KB) 
12BIOTRONIK Australia Pty Ltd (PDF 1341 KB) 
13Day Hospitals Australia (PDF 302 KB) 
14Pfizer Australia (PDF 284 KB) 
15Australian Federation of AIDS Organisations (PDF 453 KB) 
16Prostheses List Advisory Committee (PDF 435 KB) 
17Research Australia (PDF 403 KB) 
18Merck Sharp & Dohme (PDF 187 KB) 
19Haemophilia Foundation Australia (PDF 337 KB) 
20Australian Medical Device Manufacturers and Distributers (PDF 314 KB) 

(Select multiple items for download by clicking the checkboxes)

Download Selected

About this inquiry

On 9 February 2017, the Senate referred the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 to the Senate Community Affairs Legislation Committee for inquiry and report.

Submissions were sought by 3 March 2017. The reporting date is 27 March 2017.

Past Public Hearings

17 Mar 2017: Canberra


Inquiry Status

Report tabled


If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at